TX HB4533 | 2025-2026 | 89th Legislature

Status

Sponsorship: Partisan Bill (Republican 1)
Status: Introduced on March 12 2025 - 25% progression, died in committee
Action: 2025-04-03 - Referred to Human Services
Pending: House Human Services Committee
Text: Latest bill text (Introduced) [HTML]

Summary

Relating to the reimbursement of prescription drugs under Medicaid and the child health plan program.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Relating to the reimbursement of prescription drugs under Medicaid and the child health plan program.

Sponsors


History

DateChamberAction
2025-04-03HouseReferred to Human Services
2025-04-03HouseRead first time
2025-03-12HouseFiled

Subjects


Texas State Sources


LegiScan Search

View Top 50 Searches

Select area of search.
Find an exact bill number.
Search bill text and data. [help]
Reset

LegiScan Trends

View Top 50 National

CA AB2679 State highways: public parking: traffic control.
PA HB2712 Further providing for definitions and for confidentiality of review organization's...
CA AB1664 Elections: law enforcement investigations of election records or voting...
MA H3073 Supporting families through enhanced tax credits
CA AB1640 California Restaurant Reservation AntiPiracy Act.
CA SB762 Transactions and use taxes: various jurisdictions.
CA AB1916 Courts: court interpreters.
NJ A1516 Exempts poll workers wages from affecting unemployment compensation.
CA AB2576 Transit-oriented development: exclusions: historic sites.
NC S1001 Coastal Regulatory Reform
feedback